ARTICLE | Distillery Therapeutics
Inflammation
October 18, 2018 6:40 PM UTC
Rat studies suggest antagonizing TRPV1 or combined antagonism of its upstream activators LPAR1, LPAR2, LPAR3 and LPAR4 could help treat allergic asthma. In a rat model of allergic asthma, plasma level...
BCIQ Company Profiles